ING Groep NV (ING) is offering a portfolio of data center loans worth roughly $500 million for sale
The Marzetti Co (MZTI) reported a 2.4% decline in net sales and a 37.4% drop in diluted EPS, but management expects recovery in the second half driven...
Cantor Fitzgerald analyst Derek Soderberg maintains NuScale Power (NYSE:SMR) with a Overweight and lowers the price target from $20 to $15.
2026-11-06. The following slide deck was published by TeraWulf Inc.
Global Partners (NYSE:GLP) reported quarterly earnings of $1.26 per share which missed the analyst consensus estimate of $1.61 by 21.74 percent. This ...
Stock futures mixed as DraftKings plunged 21% after earnings missed estimates and FY26 guidance was cut; several other stocks also fell premarket.
2026-11-06. The following slide deck was published by Mettler-Toledo International Inc.
Iovance Biotherapeutics, Inc. delivered strong Q3 results, with revenues up ~80% YoY and gross margin rising to 60%. Read why IOVA stock is a buy.
Microchip beat Q2 earnings and sales estimates but guided Q3 below forecasts. Shares fell 2.1%; analysts cut price targets despite Buy/Overweight call...
2026-11-06. The following slide deck was published by Barings BDC Inc in conjunction with their 2026 Q3 earnings call.
Fox Corp (FOX) posted record first-quarter revenue of $4.6 billion and EBITDA of $1.64 billion, driven by FIFA World Cup advertising, record midterm p...
Ascendis Pharma A/S (NASDAQ:ASND) today announced that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has a...
Airbnb stock surges as Q3 earnings top expectations with $4.87B in revenue, an upbeat outlook, and a new $12B buyback program.
Acrivon Therapeutics, Inc. ("Acrivon" or "Acrivon Therapeutics") (Nasdaq: ACRV), a clinical stage biotechnology company discovering an...
2026-11-06. The following slide deck was published by Lincoln National Corporation in conjunction with their 2026 Q3 earnings call.
Cantor Fitzgerald analyst Olivia Brayer Saunders maintains MannKind (NASDAQ:MNKD) with a Overweight and raises the price target from $8 to $10.
Dauch (NYSE:DCH) affirms FY2026 sales outlook from $10.800 billion-$10.875 billion to $10.800 billion-$10.875 billion vs $10.746 billion estimate.
After the last two, the stock rose 24% and then almost doubled. Can it rebound like that again?
TEVA scores 10/10 on ChartMill technical and setup quality, with a breakout entry at $42.11 and exit at $40.66 as trends stay strong.
Loading...